Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. OWC Pharmaceutical Research Corp. (OWCP) Message Board

WE hold a patent....we are working towards the gra

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 15624
(Total Views: 352)
Posted On: 02/26/2019 10:42:49 AM
Avatar
Posted By: Pussim
Re: Hitbodedut10 #14326
WE hold a patent....we are working towards the granting of said patent...so right now we have IP that outlines exactly how our pill is to be made...that holds true for any company that is developing a pill..

As I pointed out last week, GW pharma had their EPIDOLEX epilepsy patent challenged in court by Insys....There was the main part of GW's patent which was then broken down into 13 sub patents.
Insys spent more than 2 million dollars to challenge GW...and they were successful in having the first 2 of 13 patents struck down...

Even though GW's EPIDOLEX was granted FDA approval...they survived the challenge on the 11 other patents but lost on the first 2...

It is speculated that Insys spent this money because they want to develop a similar product to GW's EPIDOLEX...the big difference being Insys will use naturally derived cannabis extracts...

EPIDOLEX is synthetic and one study has shown that over time synthetic cannabis loses its potency over time while naturally derived cannabis maintains its' potency.

You can begin to understand why the company is now entering into phase 2 on a few of it's products as phase 1 is always about the safety of a product to make sure it has no toxic effects on a patient...

Phase 2 is all about efficacy where they study how the drug works and does it perform as they expect in terms of blood levels for example,

The PK study is a blood study which will draw more than 240 vials of blood over a set period of time and analyze the constituents of the drug into the blood..

This is how efficacy can be studied...and just one of the ways of proving efficacy...



(0)
(0)




OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us